Form 4: Anika Therapeutics CEO Cheryl Blanchard Reports Stock Transactions
SEC Form 4
Cheryl Blanchard, CEO of Anika Therapeutics, reports the vesting of restricted stock units and related stock transactions.
Summary
- Cheryl Blanchard, the CEO and a director of Anika Therapeutics, reported several transactions involving the company's common stock on March 11, 2024.
- These transactions include the vesting of restricted stock units (RSUs) and the subsequent withholding of shares to cover tax obligations.
- Blanchard also reported the transfer of 11,742 shares to The Cheryl R. Blanchard Amended and Restated Revocable Trust.
- The reported transactions resulted in an increase in Blanchard's directly held shares and derivative securities, and a decrease due to tax withholdings.
- After these transactions, Blanchard directly owns 151,694 shares of common stock and indirectly owns 11,742 shares through a revocable trust.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common for publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| December 19, 2014 | Date of The Cheryl R. Blanchard Amended and Restated Revocable Trust |
| March 9, 2021 | Date of grant of Restricted Stock Units (RSUs) that vested in three equal annual installments beginning March 9, 2022 |
| March 11, 2022 | Date of grant of Restricted Stock Units (RSUs) that vested in three equal annual installments beginning March 11, 2023 |
| May 12, 2023 | 152 shares purchased under the Anika Therapeutics, Inc. Employee Stock Purchase Plan |
| March 9, 2023 | Date of grant of Restricted Stock Units (RSUs) that vested in three equal annual installments beginning March 9, 2024 |
| November 14, 2023 | 787 shares purchased under the Anika Therapeutics, Inc. Employee Stock Purchase Plan |
| March 8, 2024 | Closing price of ANIK common stock prior to RSU vesting ($25.42) |
| March 9, 2024 | Vesting date of RSUs granted on March 9, 2023 |
| March 11, 2024 | Date of stock transactions, including RSU vesting and tax withholding |
| March 11, 2024 | Closing price of ANIK common stock on the trading day of RSU vesting ($25.79) |
| March 12, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.